Abstract:Background: Antibiotic resistance is a serious public health problem as it causes previously manageable diseases to become deadly infections that can cause serious disability or even death. Scientists are creating novel approaches and procedures that are essential for the treatment of infections and limiting the improper use of antibiotics in an effort to counter this rising risk. Objectives: With a focus on the numerous postbiotic metabolites formed from the beneficial gut microorganisms, their potential antimicrobial actions, and recent associated advancements in the food and medical areas, this review presents an overview of the emerging ways to prevent antibiotic resistance. Results: Presently, scientific literature confirms that plant-derived antimicrobials, RNA therapy, fecal microbiota transplantation, vaccines, nanoantibiotics, haemofiltration, predatory bacteria, immunotherapeutics, quorum-sensing inhibitors, phage therapies, and probiotics can be considered natural and efficient antibiotic alternative candidates. The investigations on appropriate probiotic strains have led to the characterization of specific metabolic byproducts of probiotics named postbiotics. Based on preclinical and clinical studies, postbiotics with their unique characteristics in terms of clinical (safe origin, without the potential spread of antibiotic resistance genes, unique and multiple antimicrobial action mechanisms), technological (stability and feasibility of largescale production), and economic (low production costs) aspects can be used as a novel alternative agent or adjuvant for the common antibiotics utilized in the production of animal-based foods. Conclusion: Postbiotic constituents may be a new approach for utilization in the pharmaceutical and food sectors for developing therapeutic treatments. Further metabolomics investigations are required to describe novel postbiotics and clinical trials are also required to define the sufficient dose and optimum administration frequency of postbiotics.

Postbiotic nanoparticles (postbiotics-NPs): a novel strategy for providing probiotics' health advantages through food consumption

Postbiotics as the new frontier in food and pharmaceutical research

Postbiotics: Functional Food Materials and Therapeutic Agents for Cancer, Diabetes, and Inflammatory Diseases

Postbiotics: Current Trends in Food and Pharmaceutical Industry

Postbiotics: Enhancing human health with a novel concept

Potential in vivo delivery routes of postbiotics

Promising bioactivities of postbiotics: A comprehensive review

Postbiotics: The concept and their use in healthy populations

Postbiotics: An overview of concepts, inactivation technologies, health effects, and driver trends

Synergistic interaction of nanoparticles and probiotic delivery: A review

Recent advances and potentiality of postbiotics in the food industry: Composition, inactivation methods, current applications in metabolic syndrome, and future trends

Postbiotics in Human Health: A Narrative Review

Postbiotics, as Dynamic Biomolecules, and Their Promising Role in Promoting Food Safety

Postbiotic as Novel Alternative Agent or Adjuvant for the Common Antibiotic Utilized in the Food Industry

A Comprehensive Overview of Postbiotics with a Special Focus on Discovery Techniques and Clinical Applications

The Concept of Postbiotics

Prebiotics, Probiotics and Postbiotics: The Changing Paradigm of Functional Foods

Exploring the Potential of Postbiotics for Food Safety and Human Health Improvement

Postbiotics are a candidate for new functional foods

Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond

The Current and Future Perspectives of Postbiotics